Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-03-24 @ 10:30 PM
Study NCT ID:
NCT00534833
Status:
COMPLETED
Last Update Posted:
2013-11-21
First Post:
2007-09-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-24
First Submit QC Date:
None
Study First Post Date:
2007-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-19
Results First Submit QC Date:
None
Results First Post Date:
2013-11-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-19
Last Update Post Date:
2013-11-21
Last Update Post Date Type:
ESTIMATED